Tyson Foods, Inc. (TSN) Stock Price & Analysis
Tyson Foods, Inc. (TSN) closed at USD 57.07 on Thursday, October 22, 2026, up 2.09% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 55.9; the Oct 22, 2026 session ranged USD 55.89–57.18 on volume of 3,337,748 shares. Market capitalization is $20.08B, with a 52-week range of USD 49.96–69.48 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:26 UTC.
Also available as compact Markdown for AI agents: nexqual.com/TSN.md
Key facts (TSN)
- Last four reported quarters (through Jun 27, 2026): revenue $55.7B, net income $574M (1.0% margin), free cash flow $1.16B (SEC filings).
- 6 of 80 tracked superinvestors hold TSN (13F, Q2 2026 (1 investor on Q3 2026, filed early)): 1 new, 3 added, 2 reduced, 0 unchanged.
- Total return with dividends: 1Y +14.0% vs S&P 500 +14.9%; 5Y -18.9% vs S&P 500 +80.3%.
- Next earnings: 2026-11-16, EPS estimate USD 0.6, revenue estimate $14.2B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (TSN)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $47.0B | $53.3B | $52.9B | $53.3B | $54.4B | $55.7B |
| Gross profit | $6.53B | $6.67B | $2.63B | $3.63B | $3.56B | — |
| Operating income | $4.40B | $4.41B | -$395M | $1.41B | $1.10B | $1.26B |
| Net income | $3.05B | $3.24B | -$648M | $800M | $474M | $574M |
| EPS (diluted) | $8.34 | $8.92 | -$1.87 | $2.25 | $1.33 | — |
| Free cash flow | $2.63B | $800M | -$187M | $1.46B | $1.18B | $1.16B |
| Gross margin | 13.9% | 12.5% | 5.0% | 6.8% | 6.5% | — |
| Operating margin | 9.3% | 8.3% | -0.7% | 2.6% | 2.0% | 2.3% |
| Net margin | 6.5% | 6.1% | -1.2% | 1.5% | 0.9% | 1.0% |
| Revenue growth | +8.9% | +13.2% | -0.8% | +0.8% | +2.1% | — |
| Cash + short-term investments | $2.51B | $1.03B | $573M | $1.72B | $1.23B | — |
| Total debt | $9.35B | $8.32B | $9.51B | $9.79B | $8.83B | — |
Fiscal years end Sep. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 27, 2026) (TSN)
P/E at fiscal year-ends: Sep 2025 40.9x, Sep 2024 26.5x.
Superinvestors (SEC 13F-HR, Q2 2026) (TSN)
6 of 80 tracked investors hold TSN (1 investor on Q3 2026, filed early). Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change | Quarter |
|---|---|---|---|---|---|
| Christopher Davis | Davis Advisors | 3.11% | $724M | Reduced -3.3% | Q2 2026 |
| Richard Pzena | Pzena Investment Management | 2.86% | $974M | Reduced -0.8% | Q2 2026 |
| David Katz | Matrix Asset Advisors | 2.42% | $29.4M | Added +17.6% | Q3 2026 |
| Yacktman Asset Management | 1.83% | $148M | Added +2.5% | Q2 2026 | |
| Thomas Gayner | Markel Group | 0.40% | $52.3M | Added +2.7% | Q2 2026 |
| Lee Ainslie | Maverick Capital | 0.01% | $1.6M | New position | Q2 2026 |
Analysts (TSN)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-07 | Piper Sandler | Target lowered | Overweight | $66 → $56 |
| 2026-09-18 | JP Morgan | Upgrade | Neutral → Overweight | $65 → $63 |
| 2026-09-10 | Piper Sandler | Target lowered | Overweight | $78 → $66 |
| 2026-09-04 | BMO Capital | Target lowered | Outperform | $75 → $65 |
| 2026-09-04 | Barclays | Target lowered | Overweight | $78 → $75 |
| 2026-07-14 | JP Morgan | Target lowered | Neutral | $71 → $65 |
| 2026-07-02 | B of A Securities | Target lowered | Neutral | $70 → $68 |
| 2026-07-02 | Bernstein | Target lowered | Market Perform | $72 → $63 |
Total return (dividends reinvested) (TSN)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +14.0% | -18.9% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +14.1% | -4.1% |
| Volatility (annualized) | 26.7% | 24.8% |
| Max drawdown | -25.3% (May 2026→Oct 2026) | -51.1% (Feb 2022→Oct 2023) |
TSN analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.60 | $1.22 | -50.7% | $14.17B | 8 |
| Next quarter (ends Dec 2026) | $0.97 | $1.11 | -12.6% | $14.27B | 6 |
| Current fiscal year (ends Sep 2026) | $3.55 | $4.03 | -11.9% | $56.24B | 10 |
| Next fiscal year (ends Sep 2027) | $3.90 | $4.48 | -13.1% | $55.44B | 10 |
Key Statistics (as of October 23, 2026 at 09:26 UTC)
| Price | USD 57.07 |
|---|---|
| Change | ▲ 2.09% (up) |
| Previous Close | USD 55.9 |
| Open | USD 55.93 |
| Day Range | USD 55.89 – 57.18 |
| 52-Week Range | USD 49.96 – 69.48 |
| Volume | 3,337,748 shares |
| Market Cap | $20.08B |
| Exchange | NYQ |
Technical Analysis (TSN)
Nexqual's technical model rates TSN "BUY" based on 5 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:26 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 75.26 (overbought) |
| vs SMA50 | Above (USD 53.93) |
| MACD | 0.73 (positive) |
Earnings (TSN)
| Next Earnings Date | 2026-11-16 |
|---|---|
| EPS Estimate | USD 0.6 |
| Revenue Estimate | $14.17B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.99 vs est 0.99 ▲ beat |
| 2026-03-31 | USD 0.87 vs est 0.78 ▲ beat |
| 2025-12-31 | USD 0.97 vs est 0.94 ▲ beat |
| 2025-09-30 | USD 1.15 vs est 0.83 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financials & Fundamentals (TSN)
| Total Revenue | $55.69B |
|---|---|
| Revenue Growth (latest quarter, YoY) | -0.10% |
| Gross Margin | +6.55% |
| Operating Margin | +2.71% |
| Profit Margin | +1.03% |
| ROE | +3.26% |
| Debt / Equity | 0.44 |
| Current Ratio | 1.43 |
| Total Cash | $740.00M |
| Total Debt | $8.01B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $1.16B (2.1% of revenue) |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financial Health Score (TSN)
Nexqual rates Tyson Foods, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:26 UTC.
| Growth | Mixed — Revenue +2.1% YoY (annual), slow |
|---|---|
| Profitability | Weak — Gross margin 7%, operating 3% (last 12 months) |
| Balance Sheet | Solid — $740M cash and investments vs $8.01B debt (Jun 2026, SEC) |
| Cash Flow | Mixed — FCF $1.16B (last 4 quarters to Jun 2026, SEC), slim 2.1% margin |
| Efficiency | Weak — ROE 3%, ROA 2.6% |
Ownership (TSN)
| Insider Ownership | +2.61% |
|---|---|
| Institutional Ownership | +94.37% |
| Shares Outstanding | 281.79M |
| Float | 274.49M |
| Short % of Float | +3.15% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BG | Bunge Limited | USD 103.15 | ▲ 0.9% |
| ADM | Archer-Daniels-Midland Company | USD 79.84 | ▲ 0.6% |
| CALM | Cal-Maine Foods, Inc. | USD 63.83 | ▲ 5.31% |
| AGRO | Adecoagro S.A. | USD 9.83 | ▲ 3.69% |
| DMC | Del Monte Corporation | USD 29.93 | ▲ 7.28% |
| DOLE | Dole plc | USD 13.52 | ▲ 3.13% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:26 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt